Randomized phase II trial of autologous dendritic cells loaded with autologous tumor cell antigens from self-renewing cancer cells in patients with newly diagnosed stage III or IV ovarian cancer

被引：0
|
作者：
Abaid, Lisa [1 ]
Friedman, Richard [2 ]
Brown, John [1 ]
Mendivil, Alberto [1 ]
Beck, Tiffany [1 ]
Corr, Bradley [3 ]
Randall, Leslie [4 ]
Mason, James [5 ]
Hsieh, Candace [6 ]
Nistor, Gabriel [6 ]
Dillman, Robert [6 ]
机构：
[1] Hoag Hosp, Newport Beach, CA USA
[2] Disney Family Canc Ctr, Burbank, CA USA
[3] Univ Colorado, Aurora, CO USA
[4] Univ Calif Irvine, Orange, CA 92668 USA
[5] Scripps Green & Mem Hosp, La Jolla, CA USA
[6] AiVita Biomed Inc, Irvine, CA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2019年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P391
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II trial of therapeutic vaccine consisting of autologous dendritic cells loaded with autologous tumor cell antigens from self-renewing cancer cells in patients with newly diagnosed glioblastoma
    Bota, Daniela
    Piccioni, David
    LaRocca, Renato
    Duma, Christopher
    Aiken, Robert
    Kesari, Santosh
    Carrillo, Jose
    Taylor, Thomas
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines
    Dillman, Robert O.
    Nistor, Gabriel I.
    Keirstead, Hans S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [3] PHASE II TRIAL OF IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS PRESENTED BY AUTOLOGOUS DENDRITIC CELL VACCINE
    Bota, Daniela
    Piccioni, David
    Duma, Christopher
    LaRocca, Renato
    Kesari, Santosh
    Carrillo, Jose
    O'Donnell, Robert
    Aiken, Robert
    Hsu, Frank
    Kong, Xiao-Tang
    Taylor, Thomas
    Nistor, Gabriel
    Dillman, Robert
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A196 - A196
  • [4] Treatment-related adverse events in a randomized trial in stage three and four ovarian cancer testing patient-specific dendritic cell vaccines loaded with tumor antigens from self-renewing autologous tumor cells
    Corr, Bradley
    Abaid, Lisa
    Mason, James
    Eskander, Ramez
    Cappuccini, Fabio
    Friedman, Richard
    Lopez, Katrina
    Nistor, Gabriel
    Dillman, Robert
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S164 - S164
  • [5] PATIENT-SPECIFIC DENDRITIC CELL VACCINE (DC-ATA) PULSED WITH ANTIGENS FROM SELF-RENEWING AUTOLOGOUS TUMOR CELLS IN THE TREATMENT OF NEWLY-DIAGNOSED GLIOBLASTOMA: A PHASE II TRIAL
    Bota, Daniela
    Piccioni, David
    LaRocca, R.
    Duma, Christopher
    Kesari, Santosh
    Carrillo, Jose
    O'Donnell, Robert T.
    Aiken, Robert
    Hsu, Frank
    Kong, Xiao-Tang
    Hsieh, Candace
    Langford, Chris
    Carta, Krystal
    Wang, Adrienne
    Langford, James
    Taylor, Thomas
    Nistor, Gabriel
    Dillman, Robert
    NEURO-ONCOLOGY, 2020, 22 : 38 - 39
  • [6] Phase II Trial of Dendritic Cells Loaded with Antigens from Self-Renewing, Proliferating Autologous Tumor Cells as Patient-Specific Antitumor Vaccines in Patients with Metastatic Melanoma: Final Report
    Dillman, Robert O.
    Selvan, Senthamil R.
    Schiltz, Patric M.
    McClay, Edward F.
    Barth, Neil M.
    DePriest, Carol
    de Leon, Cristina
    Mayorga, Cheryl
    Cornforth, Andrew N.
    Allen, Kanoe
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2009, 24 (03) : 311 - 319
  • [7] Randomized phase II trial of patient specific dendritic cell vaccines loaded with autologous tumor antigens versus autologous monocytes in patients with primary advanced ovarian cancer.
    Dillman, Robert O.
    Abaid, Lisa
    Hsieh, Candace
    Langford, Christopher
    Nistor, Gabriel I.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [8] Manufacturing patient-specific autologous dendritic cell vaccines targeting antigens from autologous tumor cells that were self-renewing in liquid cell culture and injecting such vaccines to treat patients with advanced cancer
    Dillman, Robert O.
    Nistor, Gabriel I.
    Keirstead, Hans S.
    CANCER IMMUNOLOGY RESEARCH, 2025, 13 (02)
  • [9] PHASE II TRIAL OF VACCINE IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ADJUNCTIVE AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE FROM IRRADIATED SELF-RENEWING AUTOLOGOUS TUMOR CELLS (AV-GBM-1)
    Bota, Daniela A.
    Piccioni, David E.
    Duma, Christopher M.
    LaRocca, Renato V.
    Kesari, Santosh
    Abedi, Mehrdad
    Carrillo, Jose A.
    Aiken, Robert D.
    Hsu, Frank
    Kong, Xiao-Tang
    Taylor, Thomas H.
    Hsieh, Candace
    Nistor, Gabriel
    Dillman, Robert
    NEURO-ONCOLOGY, 2021, 23 : 58 - 58
  • [10] Randomized Phase II Trial of Adjuvant Autologous Tumor Cell Vaccine (FANG™) for High Risk Stage III/IV Ovarian Cancer: Preliminary Results
    Senzer, Neil
    Barve, Minal
    Bedell, Cynthia
    Oh, Jonathan
    Kuhn, Joseph
    Fine, Bruce
    Heffernan, Thomas P.
    Matthews, Carolyn M.
    Stringer, C. Allen
    Koon, E. Colin
    Lifshitz, Samuel
    Pappen, Beena O.
    Kumar, Padmasini
    Maples, Phillip B.
    Nemunaitis, John
    MOLECULAR THERAPY, 2013, 21 : S194 - S195
12345